lobbying_activities: 2507614

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2507614	ed30b2ff-da64-4745-bf92-e39d11dc7b21	Q3	KOUNTOUPES DENHAM CARR & REID, LLC	320918	GLENMARK PHARMACEUTICALS, INC., USA	2020	third_quarter	PHA	General information about the company and the industry. Issues related to affordability and pricing of pharmaceuticals. Issues related to the implementation of H.R. 748, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including drug supply chain dynamics. H.R. 6800, the HEROES Act. S. Amdt 2652, the Targeted COVID Relief Package. Issues related to the federal response to the COVID-19 pandemic. Supply chain and essential medicine manufacturing.	Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE	50000		0	0	2020-10-14T13:06:35.537000-04:00